-
DEFINING COUNTY LEVEL SOCIAL DETERMINANTS OF HEALTH BASED PHENOTYPES RELATED TO DEPRESSION IN THE UNITED STATES USING MACHINE LEARNING APPROACH
Feb 25, 2026, 14:40 PM -
ECONOMIC EVALUATION AND BUDGET IMPACT ANALYSIS OF MICROWAVE ABLATION VS. RADIOFREQUENCY ABLATION AND SURGICAL RESECTION FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA IN THE MEXICAN PUBLIC HEALTH SYSTEM
Feb 25, 2026, 14:40 PM -
COMPARISON OF GUIDELINE-RECOMMENDED AND PRELIMINARY RISK-BASED APPROACHES TO SELECTION OF LUNG CANCER PATIENTS FOR LYMPH NODE STAGING
Feb 25, 2026, 14:40 PM -
ELICITING CANCER PROGRESSION RATES FOR LOCALLY/REGIONAL RECURRENT (LR) POPULATIONS USING AGGREGATE LEVEL SURVIVAL DATA: AN ILLUSTRATION FROM MELANOMA
Feb 25, 2026, 14:40 PM -
COST OF AMPUTATION FOLLOWING LOWER EXTREMITY ENDOVASCULAR REVASCULARIZATION IN PERIPHERAL ARTERY DISEASE
Feb 25, 2026, 14:40 PM -
MODELING APPROACHES FOR VACCINE INDIRECT EFFECTS IN ECONOMIC EVALUATIONS: A SCOPING REVIEW OF PUBLISHED REVIEWS AND METHODOLOGICAL GUIDANCE
Feb 25, 2026, 14:40 PM -
PATIENT PREFERENCES FOR TREATMENT SELECTION IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): A SYSTEMATIC LITERATURE REVIEW (SLR)
Feb 25, 2026, 14:40 PM -
FIRST-YEAR COST PER RESPONDER FOR BRODALUMAB COMPARED WITH OTHER BIOLOGIC THERAPIES FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN CANADA
Feb 25, 2026, 14:40 PM -
CLINICAL VALIDATION OF A MACHINE-LEARNING-ENRICHED IMMUNE-MEDIATED NECROTIZING MYOPATHY COHORT USING LINKED LABORATORY AND CLAIMS DATA
Feb 25, 2026, 14:40 PM -
STRATEGIC COMPARISON OF CENTER FOR PHARMACOECONOMICS AND INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ECONOMIC EVALUATIONS
Feb 25, 2026, 14:40 PM -
IMPACT OF TAFAMIDIS USE IN COLOMBIAN PATIENTS DIAGNOSED WITH ATTR-CM ON HEALTH-RELATED QUALITY OF LIFE DURING TWO YEARS OF FOLLOW-UP: REAL WORLD STUDY IN COLOMBIA
Feb 25, 2026, 14:40 PM -
CO-PAYMENT FOR ALK SUBLINGUAL IMMUNOTHERAPY TABLETS PAID BY PATIENTS ENROLLED IN A PATIENT SUPPORT PROGRAM IN BRITISH COLUMBIA
Feb 25, 2026, 14:40 PM -
AN ALGORITHM TO IDENTIFY LESS INVASIVE SURFACTANT ADMINISTRATION USING A REAL-WORLD DATABASE OF PRETERM INFANTS
Feb 25, 2026, 14:40 PM -
ECONOMIC VALUE OF RELAPSE RATE REDUCTION WITH OFATUMUMAB VERSUS COMPARATOR DISEASE-MODIFYING THERAPIES IN RELAPSING MULTIPLE SCLEROSIS: A FIVE-YEAR BUDGET IMPACT ANALYSIS WITH CLINICAL OUTCOME OFFSETS
Feb 25, 2026, 14:40 PM -
ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS
Feb 25, 2026, 14:40 PM -
A NOVEL MULTIVARIATE APPLICATION OF PROFILE ANALYSIS TO CHARACTERIZE MULTIDOMAIN PATIENT-REPORTED OUTCOME (PRO) PATTERNS IN PATIENTS WITH GASTRIC OR GASTROESOPHAGEAL JUNCTION (GC/GEJC) ADENOCARCINOMA
Feb 25, 2026, 14:40 PM -
INTERPROVINCIAL DISPARITIES IN ACCESS TO DERMATOLOGY TREATMENTS IN CANADA
Feb 25, 2026, 14:40 PM -
HEALTHCARE RESOURCE UTILIZATION IN LONG-TERM CARE RESIDENTS WITH AGITATION ASSOCIATED WITH DEMENTIA DUE TO ALZHEIMER’S DISEASE TREATED WITH BREXPIPRAZOLE
Feb 25, 2026, 14:40 PM -
SOURCES OF HOSPITAL ADMISSION COSTS IN HTA SUBMISSIONS IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Feb 25, 2026, 14:40 PM -
A FRAMEWORK FOR INTEGRATING THE ESTIMANDS INTO FEASIBILITY OF NETWORK META-ANALYSES OF RANDOMIZED CONTROLLED TRIALS
Feb 25, 2026, 14:40 PM
